Skip to main content
. Author manuscript; available in PMC: 2024 Jan 18.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2023 Jan 18;37(1):20–27. doi: 10.1097/WAD.0000000000000538

TABLE 4.

Adjusted hazards ratios for anticholinergic drug use on developing dementia#

Model 4 Model 5 Model 6
Variable HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Age 1.1 (1.1, 1.2) <0.001 1.1 (1.1, 1.2) <0.001 1.1 (1.1, 1.2) <0.001

Female 1.0 (0.7, 1.5) 0.799 1.0 (0.7, 1.5) 0.846 1.0 (0.7, 1.5) 0.812

Education
 < high school Reference Reference Reference
 = high school 0.7 (0.4, 1.1) 0.126 0.7 (0.5, 1.1) 0.137 0.7 (0.5, 1.1) 0.130
 > high school 0.6 (0.4, 1.0) 0.040 0.6 (0.4, 1.0) 0.042 0.6 (0.4, 1.0) 0.041

Total number of prescription medications
 <3 Reference Reference Reference
 3-6 0.9 (0.6, 1.4) 0.563 0.9 (0.6, 1.4) 0.524 0.9 (0.5, 1.4) 0.515
 >6 0.9 (0.6, 1.6) 0.824 0.9 (0.5, 1.5) 0.647 0.9 (0.5, 1.6) 0.641

Take any anticholinergic drug 0.9 (0.6, 1.4) 0.641

Total ACR score
 0 Reference
 1-3 0.9 (0.5, 1.4) 0.516
 >3 1.1 (0.6, 1.9) 0.825
 >3 versus 1-3 # 1.2 (0.8, 1.9) 0.340

Total number of anticholinergic drugs
 0 Reference
 1-2 0.9 (0.6, 1.4) 0.573
 >2 1.0 (0.6, 1.9) 0.915
 >2 versus 1-2 * 1.2 (0.7, 1.9) 0.498

Abbreviations: HR, hazard ratio; CI, confidence interval.

#

Dementia was defined as clinical dementia rating (CDR) score ≥1.

#

is comparing total ACR score of >3 to 1-3 (the reference)

*

is comparing total number of anticholinergic drugs of >2 to 1-2 (the reference).

Models 4, 5, 6 used any anticholinergic drug use, total ACR score, total number of anticholinergic drugs as the main predictor, respectively.